Hypericin uptake: A prognostic marker for survival in high-grade glioma

Journal of Clinical Neuroscience

Volumn 15, Issue 7, 2008, Pages 778-783

  Ritz, R ^a   Muller M ^a   Dietz, K ^a   Duffner, F ^a   Bornemann, A ^a   Roser, F ^a   Tatagiba, M ^a  

^a UNIVERSITY OF TÜBINGEN   (Germany)

Author keywords

Glioblastoma; Hypericin; Photodynamic therapy; Prognosis

Indexed keywords

HYPERICIN; LOMUSTINE; LOW DENSITY LIPOPROTEIN; NIMUSTINE; PROCARBAZINE; TEMOZOLOMIDE; TENIPOSIDE; VINCRISTINE;

ADULT; ARTICLE; CANCER CELL CULTURE; CANCER SURGERY; CANCER SURVIVAL; CELL PROLIFERATION; CLINICAL ARTICLE; CONTROLLED STUDY; CULTURE MEDIUM; DISEASE SEVERITY; FEMALE; FLUORESCENCE MICROSCOPY; GLIOBLASTOMA; HUMAN; HUMAN CELL; MALE; PARAMETRIC SURVIVAL MODEL; PHOTODYNAMIC THERAPY; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; STATISTICAL ANALYSIS; SURVIVAL RATE; SURVIVAL TIME;

ADULT; AGED; ASTROCYTOMA; BRAIN NEOPLASMS; CELL LINE, TUMOR; CELL PROLIFERATION; DISEASE-FREE SURVIVAL; DRUG RESISTANCE, NEOPLASM; DRUG THERAPY; FEMALE; FLUORESCENCE; GLIOBLASTOMA; GLIOMA; HUMANS; LIGHT; LIPOPROTEINS, LDL; MALE; MICROSCOPY, FLUORESCENCE; MIDDLE AGED; MODELS, STATISTICAL; PERYLENE; PHOTOCHEMOTHERAPY; PREDICTIVE VALUE OF TESTS; PROGNOSIS; RADIATION-SENSITIZING AGENTS; RADIOTHERAPY; SURVIVAL RATE;

EID: 44249109673     PISSN: 09675868     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jocn.2007.03.022     Document Type: Article

References (32)

1. Ohgaki H., Dessen P., Jourde B., et al. Genetic pathways to glioblastoma: a population-based study. Cancer Res 64 (2004) 6892-6899
2. Gilbert M.R., and Loghin M. The treatment of malignant gliomas. Curr Treat Options Neurol 7 (2005) 293-303
3. Stupp R., Mason W.P., van den Bent M.J., et al. Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med 352 (2005) 987-996
4. Stylli S.S., Kaye A.H., Macgregor L., et al. Photodynamic therapy of high grade glioma: long term survival. J Clin Neurosci 12 (2005) 389-398
5. Ritz R., Müller M., Weller M., et al. Hypericin: a promising fluorescence marker for differentiating between glioblastoma and neurons in vitro. Int J Oncol 27 (2005) 1543-1549
6. Siboni G., Weitman H., Freeman D., et al. The correlation between hydrophilicity of hypericins and helianthrone: internalization mechanisms, subcellular distribution and photodynamic action in colon carcinoma cells. Photochem Photobiol Sci 1 (2002) 483-491
7. Crnolatac I., Huygens A., Agostinis P., et al. In vitro accumulation and permeation of hypericin and lipophilic analogues in 2-D and 3-D cellular systems. Int J Oncol 30 (2007) 319-324
8. Chen B., Xu Y., Roskams T., et al. Efficacy of antitumoral photodynamic therapy with hypericin: relationship between biodistribution and photodynamic effects in the RIF-1 mouse tumor model. Int J Cancer 93 (2001) 275-282
9. Kascakova S., Refregiers M., Jancura D., et al. Fluorescence spectroscopic study of hypericin-photosensitized oxidation of low-density lipoproteins. Photochem Photobiol 81 (2005) 1395-1403
10. Duffner F., Ritz R., Freudenstein D., et al. Specific intensity imaging for glioblastoma and neural cell cultures with 5-aminolevulinic acid-derived protoporphyrin IX. J Neurooncol 71 (2005) 107-111
11. Buckner J.C., Schomberg P.J., McGinnis W.L., et al. A phase III study of radiation therapy plus carmustine with or without recombinant interferon-alpha in the treatment of patients with newly diagnosed high-grade glioma. Cancer 92 (2001) 420-433
12. Curran Jr. W.J., Scott C.B., Horton J., et al. Recursive partitioning analysis of prognostic factors in three radiation therapy oncology group malignant glioma trials. J Natl Cancer Inst 85 (1993) 704-710
13. Lamborn K.R., Chang S.M., and Prados M.D. Prognostic factors for survival of patients with glioblastoma: recursive partitioning analysis. Neurooncol 6 (2004) 227-235
14. Ammirati M., Vick N., Liao Y.L., et al. Effect of the extent of surgical resection on survival and quality of life in patients with supratentorial glioblastomas and anaplastic astrocytomas. Neurosurgery 21 (1987) 201-206
15. Buckner J.C. Factors influencing survival in high-grade gliomas. Semin Oncol 30 (2003) 10-14
16. Jeremic B., Milicic B., Grujicic D., et al. Clinical prognostic factors in patients with malignant glioma treated with combined modality approach. Am J Clin Oncol 27 (2004) 195-204
17. Nafe R., Franz K., Schlote W., et al. Morphology of tumor cell nuclei is significantly related with survival time of patients with glioblastomas. Clin Cancer Res 11 (2005) 2141-2148
18. Sharma S., Sharma M.C., and Sarkar C. Morphology of angiogenesis in human cancer: a conceptual overview, histoprognostic perspective and significance of neoangiogenesis. Histopathology 46 (2005) 481-489
19. Uematsu M., Ohsawa I., Aokage T., et al. Prognostic significance of the immunohistochemical index of survivin in glioma: a comparative study with the MIB-1 index. J Neurooncol 72 (2005) 231-238
20. Rich J.N., Hans C., Jones B., et al. Gene expression profiling and genetic markers in glioblastoma survival. Cancer Res 65 (2005) 4051-4058
21. Pelloski C.E., Mahajan A., Maor M., et al. YKL-40 expression is associated with poorer response to radiation and shorter overall survival in glioblastoma. Clin Cancer Res 11 (2005) 3326-3334
22. Hegi M.E., Diserens A.C., Gorlia T., et al. MGMT gene silencing and benefit from temozolomide in glioblastoma. N Engl J Med 352 (2005) 997-1003
23. Stylli S.S., Howes M., Macgregor L., et al. Photodynamic therapy of brain tumours: evaluation of porphyrin uptake versus clinical outcome. J Clin Neurosci 11 (2004) 584-596
24. Luksiene Z., and de Witte P.A. Hypericin as novel and promising photodynamic therapy tool: studies on intracellular accumulation capacity and growth inhibition efficiency. Medicina (Kaunas) 39 (2003) 677-682
25. Ritz R., Wein H., Dietz K., et al. Photodynamic therapy of malignant glioma with hypericin: Comprehensive in vitro study in human glioblastoma cell lines. Int J Oncol 30 (2007) 659-667
26. Herz J., Hamann U., Rogne S.K., et al. Surface location and high affinity for calcium of a 500-kd liver membrane protein closely related to the LDL-receptor suggest a physiological role as lipoproteinreceptor. EMBO J 7 (1988) 4119-4127
27. Bu G., Maksymovitch E.A., Geuze H., et al. Subcellular localization and endocytic function of low density lipoprotein receptor-related protein in human glioblastoma cells. J Biol Chem 269 (1994) 29874-29882
28. Yamamoto M., Ikeda K., Ohshima K., et al. Increased expression of low density lipoprotein receptor-related protein/alpha2-macroglobulin receptor in human malignant astrocytomas. Cancer Res 57 (1997) 2799-2805
29. Saksela O., Wahström T., Lehtovirta P., et al. Presence of alpha2-macroglobulin in normal but not in malignant syncytiotrophoblasts. Cancer Res 41 (1981) 2507-2513
30. Van Leuven F., Cassiman J.-J., and Van den Berghe H. Demonstration of an alpha2-macroglobulin receptor in human fibroplasts, absent in tumor-derived cell lines. J Biol Chem 254 (1979) 5155-5160
31. Delaey E.M., Obermueller R., Zupko I., et al. In vitro study of the photocytotoxicity of some hypericin analogs on different cell lines. Photochem Photobiol 74 (2001) 164-171
32. Kleihues P., Louis D.N., Scheithauer B.W., et al. The WHO classification of tumors of the nervous system. J Neuropathol Exp Neurol 61 (2002) 215-225